Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$455K Buy
144,756
+24,478
+20% +$76.5K ﹤0.01% 2040
2026
Q1
$351K Buy
120,278
+26,572
+28% +$75.9K ﹤0.01% 1998
2025
Q4
$231K Buy
93,706
+14,660
+19% +$34.9K ﹤0.01% 2196
2025
Q3
$176K Buy
79,046
+13,973
+21% +$32K ﹤0.01% 2292
2025
Q2
$157K Buy
65,073
+9,536
+17% +$23.2K ﹤0.01% 2212
2025
Q1
$129K Sell
55,537
-62,393
-53% -$125K ﹤0.01% 2089
2024
Q4
$219K Sell
117,930
-8,339
-7% -$18.4K ﹤0.01% 2200
2024
Q3
$277K Buy
126,269
+16,500
+15% +$37K ﹤0.01% 2046
2024
Q2
$256K Buy
+109,769
New +$250K ﹤0.01% 2042

Other funds holding ABEV

Sanctuary Advisors's ABEV Position: Q2 2026 in Review

Sanctuary Advisors increased its Ambev (ABEV) stake by 20% in Q2 2026, buying an estimated $76.5K and bringing the position to 144,756 shares worth $455K. The position accounts for ﹤0.01% of the portfolio, ranked #2040.

Sanctuary Advisors first reported a position in ABEV in Q2 2024 and has held it in 9 quarters since. 403 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Sanctuary Advisors held 144,756 shares of Ambev worth $455K as of Q2 2026.
  • Sanctuary Advisors bought 24,478 Ambev shares in Q2 2026, an estimated $76.5K.
  • Ambev made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #2040 holding.
  • Sanctuary Advisors first reported a position in Ambev in Q2 2024 and has held it in 9 quarters since.
  • 403 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.